Vitamin D: Metabolism, regulation and associated diseases;Vitamine D: Métabolisme, régulation et maladies associées

Medecine/Sciences

Volumn 22, Issue 12, 2006, Pages 1095-1100

  Tissandié, Emilie ^a   Guéguen, Yann ^a   Lobaccaro, Jean Marc A ^b   Aigueperse, Jocelyne ^a   Souidi, Maâmar ^a  

^a INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE IRSN   (France)

^b CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CHOLESTANETRIOL 26 MONOOXYGENASE; CYTOCHROME P450; CYTOCHROME P450 24A1; CYTOCHROME P450 27B1; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; PARATHYROID HORMONE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHATE; UNCLASSIFIED DRUG; VITAMIN D; VITAMIN D RECEPTOR;

BONE METABOLISM; CALCIUM HOMEOSTASIS; CELL DIFFERENTIATION; CELL PROLIFERATION; ENZYME BLOOD LEVEL; ENZYME REGULATION; HUMAN; IMMUNOREGULATION; OSTEOMALACIA; OSTEOPOROSIS; REVIEW; RICKETS; TRANSCRIPTION REGULATION; VITAMIN D METABOLISM;

EID: 33845938513     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.1051/medsci/200622121095     Document Type: Review

References (37)

1. Brown AJ, Dusso AS, Slatopolsky E. Vitamin D. Am J Physiol 1999; 277: F157-75.
2. Cheng JB, Levine MA, Bell NH, et al. Genetic evidence that the human CYP2R1 is a key vitamin D 25-hydroxylase. Proc Natl Acad Sci USA 2004; 101: 7711-5.
3. Souidi M, Dubrac S, Parquet M, Lutton C. Hepatic and extrahepatic sterol 27-hydroxylase: roles in cholesterol and bile acid metabolism and associated diseases. Gastroenterol Clin Biol 2003; 27: 100-11.
4. Prosser DE, Jones G. Enzymes involved in the activation and inactivation of vitamin D. Trends Biochem Sci 2004; 29: 664-73.
5. Nykjaer A, Dragun D, Walther D, et al. endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3. Cell 1999; 96: 507-15.
6. Leheste JR, Melsen F, Wellner M, et al. Hypocalcemia and osteopathy in mice with kidney-specific megalin gene defect. FASEB J 2003; 17: 247-9.
7. Garabédian M. La 1,25dihyroxyvitamine D et son récepteur. Rev Rhum 2000; 67(suppl 2):39-41.
8. Miller WL, Portale AA. Vitamin D 1 alpha hydroxylase. Trends Endocrinol Metab 2000; 11: 315-9.
9. Garcion E, Wion-Barbot N, Montero-Menei CN, et al. New clues about vitamin D functions in the nervous system. Trends Endocrinol Metab 2002; 13: 100-5.
10. 3-hydroxylases. Steroids 2001; 66: 399-408.
11. Post SM, Duez H, Gervois PP, et al. Fibrates suppress bile acid synthesis via peroxisome proliferator-activated receptor-alpha-mediated downregulation of cholesterol 7alpha-hydroxylase and sterol 27-hydroxylase expression. Arterioscler Thromb Vasc Biol 2001; 21: 1840-5.
12. Chen W, Chiang JY. Regulation of human sterol 27-hydroxylase gene (CYP27A1) by bile acids and hepatocyte nuclear factor 4alpha (HNF4alpha). Gene 2003; 313: 71-82.
13. Quinn CM, Jessup W, Wong J, et al. Expression and regulation of sterol 27-hydroxylase (CYP27A1) in human macrophages: a role for RXR and PPARgamma ligands. Biochem J 2005; 385: 823-30.
14. Eloranta JJ, Kallak-Ublick GA. Coordinate transcriptional regulation of bile acid homeostasis and drug metabolism. Arch Biochem Biophys 2005; 433: 397-412.
15. Armbrecht HJ, Hodam TL, Boltz MA. Hormonal regulation of 25-hydroxyvitamin D3-1alpha-hydroxylase and 24-hydroxylase gene transcription in opossum kidney cells. Arch Biochem Biophys 2003; 409: 298-304.
16. Hewison M, Zehnder O, Bland R, Stewart PM. 1α-Hydroxylase and the action of vitamin D. Mol Endocrinol 2000; 25: 141-8.
17. Schiavi SC, Kumar R. The phosphatonin pathway: new insights in phosphate homeostasis. Kidney Int 2004; 65: 1-14.
18. Gao XH, Dwivedi PP, Omdahl JL, et al. Calcitonin stimulates expression of the rat 25-hydroxyvitamin D3-24-hydroxylase (CVP24) promoter in HEK-293 cells expressing calcitonin receptor: identification of signaling pathways. J Mol Endocrinol 2004; 32: 87-98.
19. Chen KS, DeLuca HF. Cloning of the human 1 alpha, 25-dihydroxyvitamin D-3 24-hydroxylase gene promoter and identification of two vitamin D-responsive elements. Biochem Biophys Acta 1995; 1263: 1-9.
20. Murayama A, Kim M, Yanagisawa J, et al. Transrepression by a liganded nuclear receptor via a bHLH activator through co-regulator switching. EMBO J 2004; 23: 1598-608.
21. Pascussi JM, Robert A, Nguyen M, et al. Possible involvement of pregnane X receptor-enhanced CVP24 expression in drug-induced osteomalacia. J Clin Invest 2005; 115: 177-86.
22. Dusso AS, Brown AJ, Slatopolsky E. Vitamin D. Am J Physiol Renal Physiol 2005; 289: F8-28.
23. Norman AW, Ishizuka S, Okamura WH. Ligands for the vitamin D endocrine system: different shapes function as agonists and antagonists for genomic and rapid response receptors or as a ligand for the plasma vitamin D binding protein. J Steroid Biochem Mol Biol 2001; 76: 49-59.
24. 3: Basic concepts. J Steroid Biochem Mol Biol 2005; 97: 93-101.
25. Holick MF. Vitamin D: A millenium perspective. J Cell Biochem 2003; 88: 296-307.
26. Holick MF. Noncalcemic actions of 1,25-dihydroxyvitamin D3 and clinical applications. Bone 1995; 17 (suppl 2): S107-11.
27. Adorini L. Immunomodulatory effects of vitamin D receptor ligands in autoimmune diseases. Int Immunopharmacol 2002; 2: 1017-28.
28. St-Arnaud R, Glorieux FH. 24, 25-Dihydroxyvitamin D: active metabolite or inactive catabolite? Endocrinology 1998; 139: 3371-4.
29. Garabédian M, Menn S, Walrant-Debray O, et al. Prevention of child and adolescent vitamin D deficiency. II. Validation of a decision-making abacus based on sun exposure and vitamin D intakes. Arch Pediatr 2005; 12: 410-9.
30. Maugars Y, Glémarec J, Guillot P, et al. Métabolisme phosphocalcique et ostéomalacie. Rev Rhum 2000; 67 (suppl 2): 95-8.
31. Breuil V, Euller-Ziegler. Nutrition et vieillissement osseux: l'ostéoporose. Nutr Clin Metab 2004; 18: 212-8.
32. Gascon-Barré M. Antiepileptic drugs and bone health. In: Dawson-Hughes B, Holick MF, eds. Nutrition and bone health. Totowa-New Jersey, USA: Humana Press, 2004: 647-66.
33. Pascussi JM, Vilarem MJ. Ostéomalacie consécutive à la prise prolongée de médicaments. Sur la piste de PXR, un récepteur impliqué dans la détoxication. Med Sci (Paris) 2005; 21: 582-3.
34. Kato S, Yoshizazawa T, Kitanaka S, et al. Molecular genetics of vitamin D-dependent hereditary rickets. Horm Res 2002; 57: 73-8.
35. Dumas R. Les rachitismes vitaminorésistants. Arch Pediatr 1999; 6: 715-9.
36. Souberbielle JC, Friedlander G, Kahan A, Cormier C. Evaluating vitamin D status. Implications for preventing and managing osteoporosis and other chronic diseases. Joint Bone Spine 2006; 73: 249-53.
37. Holick MF. Defects in the synthesis and metabolism of vitamin D. Exp Clin Endocrinol Diabetes 1995; 103: 219-27.